Cargando…
AAV-BDNF gene therapy ameliorates a hypothalamic neuroinflammatory signature in the Magel2-null model of Prader-Willi syndrome
Individuals with Prader-Willi syndrome (PWS) exhibit several metabolic and behavioral abnormalities associated with excessive food-seeking activity. PWS is thought to be driven in part by dysfunctional hypothalamic circuitry and blunted responses to peripheral signals of satiety. Previous work descr...
Autores principales: | Queen, Nicholas J., Huang, Wei, Zou, Xunchang, Mo, Xiaokui, Cao, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520877/ https://www.ncbi.nlm.nih.gov/pubmed/37766791 http://dx.doi.org/10.1016/j.omtm.2023.09.004 |
Ejemplares similares
-
Hypothalamic AAV-BDNF gene therapy improves metabolic function and behavior in the Magel2-null mouse model of Prader-Willi syndrome
por: Queen, Nicholas J., et al.
Publicado: (2022) -
Truncating mutations of MAGEL2cause Prader-Willi phenotypes and autism
por: Schaaf, Christian P., et al.
Publicado: (2013) -
A Transcriptomic Signature of the Hypothalamic Response to Fasting and BDNF Deficiency in Prader-Willi Syndrome
por: Bochukova, Elena G., et al.
Publicado: (2018) -
Single Nucleus RNA-Sequencing Reveals Overall Conservation of Hypothalamic Cell Identities but Differential Expression of Specific Genes in the Magel2 Null Mouse Model of Prader-Willi Syndrome
por: Yu, Hui, et al.
Publicado: (2021) -
Prader-Willi Syndrome and Schaaf-Yang Syndrome: Neurodevelopmental Diseases Intersecting at the MAGEL2 Gene
por: Fountain, Michael D., et al.
Publicado: (2016)